Car T Cell Therapy

• Shorter treatment time
• Patients can usually recover well with proper care and observation over 2-3 weeks
• Quick intervention time and single infusion of Car T cells
• Demonstrated remission in patients who had previously underwent multiple unsuccessful
  cancer treatments
• Advantageous in targeting and destroying cancer cells during disease relapse
• Offers better outcome compared to traditional cancer treatments, potentially leading to
  longer- term remission and improved quality of life